Corient Private Wealth
CLBT icon

Corient Private Wealth’s Cellebrite CLBT Stock Holding History

Corient Private Wealth’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$369K Sell
25,278
-44,998
-64% -$595K ﹤0.01% 2421
2026
Q1 		$970K Sell
70,276
-12,548
-15% -$189K ﹤0.01% 1681
2025
Q4 		$1.45M Buy
82,824
+275
+0.3% +$4.94K ﹤0.01% 1314
2025
Q3 		$1.53M Buy
+82,549
New +$1.3M ﹤0.01% 1200

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Corient Private Wealth's CLBT Position: Q2 2026 in Review

Corient Private Wealth reduced its Cellebrite (CLBT) stake by 64% in Q2 2026, selling an estimated $595K and leaving 25,278 shares worth $369K. The position accounts for ﹤0.01% of the portfolio, ranked #2421.

Corient Private Wealth first reported a position in CLBT in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.53M in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Corient Private Wealth held 25,278 shares of Cellebrite worth $369K as of Q2 2026.
  • Corient Private Wealth sold 44,998 Cellebrite shares in Q2 2026, an estimated $595K.
  • Cellebrite made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2421 holding.
  • Corient Private Wealth first reported a position in Cellebrite in Q3 2025 and has held it in 4 quarters since.
  • Corient Private Wealth's Cellebrite position peaked at $1.53M in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.